0001375151-19-000026.txt : 20190315
0001375151-19-000026.hdr.sgml : 20190315
20190315172140
ACCESSION NUMBER: 0001375151-19-000026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190313
FILED AS OF DATE: 20190315
DATE AS OF CHANGE: 20190315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HAWLEY ROGER
CENTRAL INDEX KEY: 0001257386
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34962
FILM NUMBER: 19686001
MAIL ADDRESS:
STREET 1: 3655 NOBEL DRIVE, SUITE 260
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZOGENIX, INC.
CENTRAL INDEX KEY: 0001375151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205300780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 550-8300
MAIL ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: ZOGENIX INC
DATE OF NAME CHANGE: 20060911
4
1
wf-form4_155268488209948.xml
FORM 4
X0306
4
2019-03-13
0
0001375151
ZOGENIX, INC.
ZGNX
0001257386
HAWLEY ROGER
C/O ZOGENIX, INC.
5959 HORTON STREET, SUITE 500
EMERYVILLE
CA
94608
1
0
0
0
Common Stock
2019-03-13
4
S
0
21211
53.0958
D
49364
D
Common Stock
2019-03-14
4
S
0
38789
52.9341
D
10575
D
The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $53.00 to $53.35, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $52.7692 to $53.3050, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Thomas Doyle, Attorney-in-fact for Roger Hawley
2019-03-15